Graeme R. Martin

7.8k total citations · 2 hit papers
56 papers, 6.5k citations indexed

About

Graeme R. Martin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Graeme R. Martin has authored 56 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 30 papers in Cellular and Molecular Neuroscience and 17 papers in Physiology. Recurrent topics in Graeme R. Martin's work include Receptor Mechanisms and Signaling (27 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Nitric Oxide and Endothelin Effects (12 papers). Graeme R. Martin is often cited by papers focused on Receptor Mechanisms and Signaling (27 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Nitric Oxide and Endothelin Effects (12 papers). Graeme R. Martin collaborates with scholars based in United Kingdom, United States and China. Graeme R. Martin's co-authors include Daniël Hoyer, P.P.A. Humphrey, Jason Hannon, Paul Hartig, P.R. Saxena, David E. Clarke, Ewan J. Mylecharane, John R. Fozard, P. Leff and Richard M. Eglen and has published in prestigious journals such as Journal of the American College of Cardiology, Pharmacological Reviews and Annals of the New York Academy of Sciences.

In The Last Decade

Graeme R. Martin

56 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

1994 2.6k citations Daniël Hoyer, David E. Clarke et al. Pharmacological Reviews profile →
Molecular, pharmacological and functional diversity of 5-HT receptors

2002 1.5k citations Daniël Hoyer, Jason Hannon et al. Pharmacology Biochemistry and Behavior profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graeme R. Martin United Kingdom	30	3.6k	3.0k	1.3k	800	556	56	6.5k
Nicholas M. Barnes United Kingdom	42	4.0k 1.1×	3.3k 1.1×	833 0.6×	867 1.1×	404 0.7×	147	7.7k
Adam Doble France	37	4.1k 1.1×	3.0k 1.0×	1.4k 1.1×	421 0.5×	448 0.8×	120	7.1k
Gavin J. Kilpatrick United Kingdom	42	3.1k 0.9×	2.7k 0.9×	905 0.7×	439 0.5×	369 0.7×	83	6.4k
Josée E. Leysen Belgium	45	3.7k 1.0×	3.4k 1.1×	656 0.5×	625 0.8×	416 0.7×	127	6.4k
P.R. Saxena Netherlands	21	2.4k 0.7×	2.1k 0.7×	1.0k 0.8×	744 0.9×	290 0.5×	53	5.0k
Pierre M. Laduron Belgium	43	5.5k 1.5×	4.9k 1.6×	1.1k 0.8×	551 0.7×	495 0.9×	177	8.3k
John W. Kebabian United States	40	6.8k 1.9×	5.7k 1.9×	973 0.7×	719 0.9×	370 0.7×	95	9.8k
Ewan J. Mylecharane Australia	18	2.5k 0.7×	2.0k 0.7×	866 0.6×	503 0.6×	290 0.5×	39	4.2k
J.E. Leysen Belgium	38	3.6k 1.0×	2.8k 0.9×	671 0.5×	1.3k 1.7×	285 0.5×	97	6.1k
Françis C. Colpaert France	53	6.0k 1.7×	3.6k 1.2×	1.7k 1.3×	667 0.8×	359 0.6×	237	9.0k

Countries citing papers authored by Graeme R. Martin

Since Specialization

Citations

This map shows the geographic impact of Graeme R. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme R. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme R. Martin more than expected).

Fields of papers citing papers by Graeme R. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme R. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme R. Martin. The network helps show where Graeme R. Martin may publish in the future.

Co-authorship network of co-authors of Graeme R. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme R. Martin. A scholar is included among the top collaborators of Graeme R. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme R. Martin. Graeme R. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Graeme R., et al.. (2002). Combined immunosuppression with cyclosporine, rapamycin, and mycophenolate mofetil controls rejection with minimal nutritional impact in experimental small intestinal transplantation. Transplantation Proceedings. 34(4). 1121–1123. 1 indexed citations

Hoyer, Daniël, Jason Hannon, & Graeme R. Martin. (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacology Biochemistry and Behavior. 71(4). 533–554. 1477 indexed citations breakdown →

Bonhaus, Douglas W., Lee A. Flippin, Robert Greenhouse, et al.. (1999). RS‐127445: a selective, high affinity, orally bioavailable 5‐HT_2B receptor antagonist. British Journal of Pharmacology. 127(5). 1075–1082. 95 indexed citations

Kilpatrick, Gavin J., Frank M. Dautzenberg, Graeme R. Martin, & Richard M. Eglen. (1999). 7TM receptors: the splicing on the cake. Trends in Pharmacological Sciences. 20(7). 294–301. 102 indexed citations

Martin, Graeme R., et al.. (1999). Synthesis and serotonergic activity of a series of 2-(N-benzyl)carboxamido-5-substituted-N,N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT1B-like receptors. Journal of the Chemical Society Perkin Transactions 1. 2699–2711. 9 indexed citations

Martin, Graeme R., et al.. (1999). Synthesis and pharmacological profile of a series of 2,5-substituted-N,N-dimethyltryptamine derivatives as novel antagonists for the vascular 5-HT1B-like receptor. Journal of the Chemical Society Perkin Transactions 1. 2713–2723. 5 indexed citations

Martin, Graeme R., Richard M. Eglen, Daniël Hoyer, Mark W. Hamblin, & Frank D. Yocca. (1998). Preface. Annals of the New York Academy of Sciences. 861(1). 11 indexed citations

Martin, Graeme R., Alan D. Robertson, Sara MacLennan, et al.. (1997). Receptor specificity and trigemino‐vascular inhibitory actions of a novel 5‐HT_1B/1D receptor partial agonist, 311C90 (zolmitriptan). British Journal of Pharmacology. 121(2). 157–164. 88 indexed citations

Gray, David W., Heather Giles, Victoria J. Barrett, & Graeme R. Martin. (1997). Sodium Dependency of Constitutive Activity at 5‐HT_1Dα/1D/β Receptors. Annals of the New York Academy of Sciences. 812(1). 236–239. 3 indexed citations

10.

Martin, Graeme R.. (1996). Inhibition of the Trigemino-Vascular System with 5-HT<sub>1D</sub> Agonist Drugs: Selectively Targeting Additional Sites of Action. European Neurology. 36(2). 13–18. 33 indexed citations

11.

Hartig, Paul, Daniël Hoyer, P.P.A. Humphrey, & Graeme R. Martin. (1996). Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Trends in Pharmacological Sciences. 17(3). 103–105. 206 indexed citations

12.

Hoyer, Daniël, David E. Clarke, John R. Fozard, et al.. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).. Pharmacological Reviews. 46(2). 157–203. 2558 indexed citations breakdown →

13.

Martin, Graeme R.. (1994). Vascular receptors for 5-hydroxytryptamine: Distribution, function and classification. Pharmacology & Therapeutics. 62(3). 283–324. 136 indexed citations

14.

Craig, Douglas A. & Graeme R. Martin. (1993). 5‐HT_1B receptors mediate potent contractile responses to 5‐HT in rat caudal artery. British Journal of Pharmacology. 109(3). 609–611. 20 indexed citations

15.

MacLennan, Stephen, et al.. (1993). Amplifying interactions between spasmogens in vascular smooth muscle. Biochemical Society Transactions. 21(4). 1145–1150. 14 indexed citations

16.

MacLennan, Stephen & Graeme R. Martin. (1992). Effect of the thromboxane A₂‐mimetic U46619 on 5‐HT₁‐like and 5‐HT₂ receptor‐mediated contraction of the rabbit isolated femoral artery. British Journal of Pharmacology. 107(2). 418–421. 34 indexed citations

17.

Martin, Graeme R., et al.. (1992). Inhibition of endothelium‐dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence. British Journal of Pharmacology. 105(3). 643–652. 58 indexed citations

18.

Chester, Adrian H., Graeme R. Martin, S Tadjkarimi, & Magdi H. Yacoub. (1990). Changes in 5-hydroxytryptamine receptor subtypes in diseased human epicardial coronary arteries. Journal of the American College of Cardiology. 15(2). A24–A24. 1 indexed citations

19.

Chester, Adrian H., Graeme R. Martin, Mikael Bodelsson, et al.. (1990). 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovascular Research. 24(11). 932–937. 103 indexed citations

20.

Martin, Graeme R. & Sara MacLennan. (1990). Analysis of the 5-HT receptor in rabbit saphenous vein examplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(2). 111–119. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact